Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Analysts See $1.05 EPS

For the current quarter, 19 analysts are projecting a mean EPS of $0.76/share. It closed at $28.05 lastly. Zotefoams plc (LON:ZTF) has 0.00% since November 13, 2016 and is. It has underperformed by 8.15% the S&P500. State Street Corp grew its stake in Teva Pharmaceutical Industries Limited by 15.9% in the 1st quarter. Brown Capital Management Llc sold 31,626 shares as the company's stock declined 15.11% while stock markets rallied. The Acadian Asset Management Llc holds 44,300 shares with $1.47 million value, down from 87,910 last quarter.

Shares of Teva Pharmaceutical Industries Limited (TEVA) traded down $0.07 during trading hours on Friday, reaching $11.78. Franklin Resources Inc. now owns 66,796,897 shares of the company's stock worth $2,218,958,000 after buying an additional 6,685,844 shares in the last quarter. Finally, Royal Bank Of Canada increased their target price on Teva Pharmaceutical Industries Limited from $8.00 to $13.00 and gave the company an "underperform" rating in a report on Sunday, November 5th. It has underperformed by 58.40% the S&P500. Monarch Capital Management Inc. boosted its stake in shares of Teva Pharmaceutical Industries by 9.4% in the second quarter. It also upped Alps Etf Tr (AMLP) stake by 124,715 shares and now owns 4.27M shares. Maxim Group has "Hold" rating and $3500 target. Therefore 11% are positive. The stock of J C Penney Company Inc (NYSE:JCP) has "Hold" rating given on Monday, July 10 by BMO Capital Markets. The company has a consensus rating of "Hold" and an average price target of $22.29. The stock has "Neutral" rating by BTIG Research on Thursday, August 25. The rating was downgraded by JMP Securities on Thursday, August 18 to "Mkt Perform". The firm has "Neutral" rating by Nomura given on Thursday, December 10. The rating was downgraded by Zacks on Tuesday, August 11 to "Buy". The firm earned "Buy" rating on Friday, July 14 by Oppenheimer. On Friday, June 2 the insider CALLEN CRAIG R bought $471,038.

Investors sentiment decreased to 0.79 in Q2 2017. Its up 0.38, from 1.21 in 2017Q1. It dropped, as 73 investors sold JCP shares while 70 reduced holdings. 43 funds opened positions while 102 raised stakes. Moreover, Cubist Systematic Strategies Limited Liability Company has 0.12% invested in InterDigital, Inc. Neuberger Berman Grp Ltd Company owns 415,053 shares. (NASDAQ:IDCC). Capstone Asset holds 0.01% or 6,429 shares in its portfolio. Barry Inv Advisors Limited Com invested in 4.25% or 341,536 shares. Stifel Finance reported 24,240 shares. Voya Inv Mngmt Limited Liability Co stated it has 300,738 shares. Glenmede Na has 3,345 shares for 0% of their portfolio. Comerica Bankshares has invested 0.04% in Omega Healthcare Investors Inc (NYSE:OHI). Jpmorgan Chase And Communication owns 232,536 shares for 0% of their portfolio. Morgan Stanley holds 0.01% in Omega Healthcare Investors Inc (NYSE:OHI) or 1.46M shares.

Teva Pharmaceutical Industries Limited (TEVA) traded down $0.16 on Friday, hitting $11.62. TEVA's profit will be $913.19 million for 3.22 P/E if the $0.90 EPS becomes a reality.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA) has average revenue estimates of $5.31 Billion, compared to low analyst estimates of $5.09 Billion and high estimates of $5.63 Billion for the current quarter. Therefore 26% are positive.

A number of other research analysts also recently issued reports on TEVA. Jefferies Group LLC reaffirmed a "hold" rating on shares of Teva Pharmaceutical Industries Limited in a research note on Tuesday, July 25th. The company was downgraded on Monday, October 30 by Citigroup. Vetr raised shares of Teva Pharmaceutical Industries from a "buy" rating to a "strong-buy" rating and set a $60.02 price target for the company in a research report on Monday, August 1st. As per Tuesday, January 31, the company rating was upgraded by Bank of America. On Tuesday, July 28 the stock rating was maintained by Argus Research with "Buy".

Fitch Ratings' announcement came three months after Moody's downgraded Teva's rating from Baa3 to Baa2, and a few days after Standard & Poor's Global announced it had changed the company's outlook to negative.

Latest News